This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Pain, Precancerous/Nonmalignant Condition, Small Intestine Cancer or Unspecified Adult Solid Tumor, Protocol Specific
and you are
between 16 and 120
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

RATIONALE: Different drug formulations and combinations of drugs may help patients with chronic pain live more comfortably. It is not yet known which regimen is most effective for chronic pain. PURPOSE: Randomized phase III trial to compare the effectiveness of different morphine formulations with or without dextromethorphan in treating chronic pain in patients who have advanced cancer.

Provided treatments

  • Drug: dextromethorphan hydrobromide
  • Drug: morphine sulfate
Tris trial is registered with FDA with number: NCT00003687. The sponsor of the trial is NCIC Clinical Trials Group and it is looking for 0 volunteers for the current phase.
Official trial title:
A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients